What it costs to find out a growth strategy was wrong after you built it

The same discovery happens either way. Made after the build, it costs an engineering quarter plus the market position that quarter would have bought. Made inside a pre-test, it costs a test. AIPath does not remove the discovery. AIPath moves it in front of the spend.

Twelve engineers, one quarter, one direction. The feature ships. Adoption is flat. The retrospective concludes that the execution was fine.

Everyone in the room already knows the answer to the next question, and nobody says it out loud: the direction was wrong, and it was wrong on the day it was chosen.

Do the arithmetic once, out loud

Take your fully loaded engineering cost for one quarter. You can compute it in about ten seconds and almost nobody has ever written it down.

Then add the two things the spreadsheet leaves out. First, the market position that quarter would have bought if it had been pointed somewhere else, which is a real cost even though no account records it. Second, the willingness of the leadership team to commit to the next direction, which drops measurably after a visible miss and is the most expensive item on the list.

That total is the price of finding out late. It is also the number your board will be working from in the next planning cycle, whether or not anyone states it.

Why the number stays hidden

Pendo's 2019 Feature Adoption Report found that roughly 80 percent of software features are rarely or never used, against global cloud research and development investment the same report put at USD 29.5 billion. That is the industry-level version of the same arithmetic.

It stays hidden at company level because no accounting system has a category for it. Wasted engineering does not appear as waste. It appears as delivered features, closed tickets and a shipped roadmap. The work was done. It was pointed in the wrong direction, and pointing is not a line item.

Companies do not fear iterating. They fear discovering.

This is the part worth being honest about. No system stops a company from finding out that a growth assumption was wrong. That finding is how companies learn, and a company that never has it is a company that never tried anything.

Iteration is a plan. Discovery is an ambush. Nobody in a leadership team objects to running the next cycle; what they dread is the moment the cycle reveals something the plan did not allow for, after the money is gone. The only variable is when that moment arrives and what it costs when it does.

Discovered after the build, it arrives at maximum expense: the engineering is spent, the launch is public, the board remembers it for years, and the team commits less readily to the next direction. Discovered inside a pre-test, the same finding arrives at test prices, the shortlist is still warm, and the replacement candidate is ready.

How do I stop spending engineering capacity on initiatives that fail after launch?

By moving the check in front of the build. AIPath converts the leading candidates into small in-market tests against a control, so a low-probability path is deprioritized before a line of code is written. Engineering capacity then goes to the direction that already produced a result rather than to the direction that argued best in the room.

Where a test is instrumented, AIPath states the result that would end the idea before the test starts. A falsifier set in advance cannot be quietly softened once the team is attached to the answer, which is the failure mode every honest post-mortem eventually names.

A test that fails is the system working. It has just deprioritized a quarter-sized mistake at test size, while the shortlist is still warm and the next candidate is ready to run.

Who this is not for

AIPath is a poor fit if your engineering capacity is committed to platform, infrastructure or compliance work rather than to growth direction, because there is no directional choice for a test to inform. It is a poor fit for an early-stage company. And it is a poor fit if the company cannot run a small market test at all, because the mechanism needs a live acquisition motion.

What this changes at the next planning meeting

The question stops being whether you are confident. Confidence was never the input that mattered.

The question becomes whether you are willing to spend a small amount to find out before you spend a large amount to commit.

Related on AIPath: How to decide what to build, Why most MVPs fail, The AIPath growth decision playbook, and Growth strategy tools, the landscape.

This article is one of six in the AIPath growth budget series. The other five: Your budget is your growth strategy, The growth option you did not fund, Growth opportunities outside your analytics, Was it the strategy or the execution, and Why growth strategy restarts every quarter.

Find out at test prices

The fastest way to judge any of this is to watch it run on a company shaped like yours rather than read about it. A live screen puts your growth question on the surface: the option set AIPath generates for it, the ranking with the assumptions exposed, and the price of finding out on the leading candidate.

Book a live screen, or try the self-serve demo first.

AIPath makes the wrong call cost a test, not a quarter.